Loading articles...
Thyroid DiseasesAfirma Molecular Testing: Unique Situations and New Prognostic Development
Afirma molecular testing aids thyroid nodule management, particularly in indeterminate cytology. New prognostic markers enhance risk stratification.
ObesityGLP-1 Weight Regain: Emerging Strategies to Sustain Loss
Strategies are emerging to mitigate weight regain post-GLP-1 receptor agonist discontinuation, focusing on sustained pharmacological intervention.
Genomic MedicineCellular Reprogramming: Reversing Age-Related Phenotypes in Vitro
Research into cellular reprogramming aims to reverse age-related cellular phenotypes, with early studies demonstrating partial reversal in vitro.
Hemophilia APersonalized Hemophilia Care: EHA 2026 Highlights Individualized Approaches
EHA 2026 discussions focused on individualized hemophilia care, moving beyond standard prophylaxis to tailored treatment strategies based on patient-specific factors.
Gene TherapyExosomes Emerge as Cell-Free Option in Regenerative Medicine
Exosomes, nanoscale vesicles, are gaining attention in regenerative medicine as a cell-free therapeutic alternative, offering potential benefits over traditional cell therapies.
LeukemiaNovel Therapies Improve Outcomes Post-cBTKi in CLL at EHA 2026
New data presented at EHA 2026 highlight emerging therapeutic strategies for chronic lymphocytic leukemia (CLL) patients progressing after covalent BTK inhibitor (cBTKi) therapy, demonstrating improved progression-free survival and response rates.
LymphomaAI in Hematology: EHA 2026 Focuses on Practical, Ethical Integration
The EHA 2026 session addresses the immediate need for hematologists to integrate AI tools ethically and practically into clinical workflows.
ObesityStrategies Emerge to Mitigate Post-GLP-1 Weight Regain
Weight regain following cessation of GLP-1 receptor agonist therapy presents a clinical challenge; emerging strategies focus on sustained pharmacological intervention and lifestyle modification.
Acute Respiratory Distress SyndromeAI Enhances Oxygen Therapy Titration, Reduces Hypoxia Duration
Artificial intelligence algorithms are demonstrating efficacy in automating oxygen therapy titration, potentially reducing episodes of hypoxia and hyperoxia.
MelanomaCAR-T Therapy Versus Bispecific Antibodies
The next phase of CAR-T addresses its biggest limitations: off-the-shelf allogeneic products, in vivo gene delivery, and bispecific antibodies that redirect T cells without any gene engineering. Sarah Mitchell and James Carter explore where the technology i...